22 min listen
Episode 33: Tackling COVID-19 Drug Discovery with Structural Genomics
Episode 33: Tackling COVID-19 Drug Discovery with Structural Genomics
ratings:
Length:
17 minutes
Released:
May 14, 2021
Format:
Podcast episode
Description
The Center for Structural Genomics of Infectious Diseases at Northwestern University was prepared for COVID-19 long before the United States economy shut down. Now over a year since COVID-19 was first recorded in the U.S., co-director Dr. Karla Satchell speaks with The Chain about the role of structural genomics in preparing for disease outbreak and response.Karla Satchell, PhD, Professor, Microbiology; Principal Investigator and Co-Director, Center for Structural Genomics of Infectious Diseases, Northwestern UniversityDr. Karla Satchell is a Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine since 2000. She is also the Principal Investigator for the NIAID-funded Center for Structural Genomics of Infectious Diseases, a multi-site center in high-throughput structure determination for microbial pathogens. In 2020, the Center dedicated significant resources to structural biology of SARS-CoV-2, including efforts to provide structural biology data to support development of novel drugs, vaccines, and therapeutics. Across all areas of research, she has published more than 100 research articles. She has also been elected as a Fellow for the American Academy of Microbiology and the American Association for the Advancement of Science.
Released:
May 14, 2021
Format:
Podcast episode
Titles in the series (63)
Episode 09: Engineered Multi-Specific Antibodies for Targeted Inhibition of Cancer Metastasis w/ Jamie Spangler by The Chain: Protein Engineering Podcast